Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | $146.16B | 36.8x | 1.83 | $301.66 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | $55.53B | 36.3x | 2.59 | $37.60 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.7% Downside | Upgrade to Pro+ | |
Fisher&Paykel Healthcare | Sydney | Healthcare | Healthcare Equipment & Supplies | $20.80B | 168.6x | -3.48 | $35.66 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Cochlear | Sydney | Healthcare | Healthcare Equipment & Supplies | $19.05B | 53.3x | 2.78 | $290.77 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
Pro Medicus Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | $17.12B | 205.8x | 5.38 | $164.39 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.8% Downside | Upgrade to Pro+ | |
Sonic Healthcare | Sydney | Healthcare | Healthcare Providers & Services | $12.96B | 25.1x | -0.98 | $26.95 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Ramsay Health Care | Sydney | Healthcare | Healthcare Providers & Services | $9.19B | 10.5x | 0.17 | $40.20 | 3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
Ramsay Health Care Pref | Sydney | Healthcare | Healthcare Providers & Services | $9.19B | 10.5x | $106.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ebos | Sydney | Healthcare | Pharmaceuticals | $6.50B | 23.6x | 3.65 | $33.41 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.9% Upside | Upgrade to Pro+ | |
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $6.36B | 124.7x | 0.61 | $19.03 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Ansell | Sydney | Healthcare | Healthcare Equipment & Supplies | $4.36B | 33.8x | -0.77 | $30.13 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.4% Upside | Upgrade to Pro+ | |
Summerset Group | Sydney | Healthcare | Healthcare Providers & Services | $2.57B | 6.8x | 0.14 | $10.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $2.32B | -44.3x | 0.85 | $7.49 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.8% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | $2.05B | 323.3x | 3.72 | $1.30 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8.9% Downside | Upgrade to Pro+ | |
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | $1.75B | 312.5x | 1.5 | $2.54 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $1.73B | 14.8x | 0.13 | $13.61 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | $1.62B | -75.8x | -2.96 | $5.41 | 4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.9% Downside | Upgrade to Pro+ | |
Primary Health Care | Sydney | Healthcare | Healthcare Providers & Services | $1.22B | -1.7x | 0.04 | $1.68 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -12.3% Downside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | $1.09B | -7x | -0.53 | $0.96 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.9% Upside | Upgrade to Pro+ | |
Nanosonics | Sydney | Healthcare | Healthcare Equipment & Supplies | $1.08B | 82.3x | -2.36 | $3.54 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.7% Downside | Upgrade to Pro+ | |
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | $765.65M | -47x | 3.29 | $0.43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | $750.97M | -1.2x | 0.28 | $0.61 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.2% Downside | Upgrade to Pro+ | |
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | $748.16M | 21.5x | 1.14 | $15.12 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paragon Care Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | $703.50M | 47.2x | -0.89 | $0.42 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.4% Upside | Upgrade to Pro+ | |
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | $666.80M | 26.8x | -0.82 | $3.38 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.8% Upside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $653.25M | -13.8x | 0.4 | $0.14 | 11.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Integral Diagnostics Ltd | Sydney | Healthcare | Healthcare Providers & Services | $594.15M | -9.8x | 0.03 | $2.53 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | $585.40M | -11.2x | -0.65 | $0.41 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oceania Healthcare | Sydney | Healthcare | Healthcare Providers & Services | $514.20M | 17.5x | 0.19 | $0.71 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Monash IVF Group Ltd | Sydney | Healthcare | Healthcare Providers & Services | $463.67M | -70x | 0.52 | $1.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ |